NCT05075798View on ClinicalTrials.gov

Study of Cerebral MRI Anomalies in Mutated Transthyretin Amyloidosis Patients

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

October 25, 2021

Primary Completion Date

May 31, 2022

Study Completion Date

May 31, 2022

Conditions
Transthyretin Amyloidosis
Interventions
OTHER

No intervention,

pure observational study

Trial Locations (1)

30029

CHU de Nîmes, Nîmes

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nīmes

OTHER

NCT05075798 - Study of Cerebral MRI Anomalies in Mutated Transthyretin Amyloidosis Patients | Biotech Hunter | Biotech Hunter